[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337394-105":59,"doc-detail-337394-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-validation-of-artificial-intelligence-based-analysis-software-to-support-screening-system-of-cervical-intraepithelial-neoplasia","Development and validation of artificial intelligence-based analysis software to support screening system of cervical intraepithelial neoplasia","","Cervical cancer is a leading cause of death in women worldwide and arises from cervical intraepithelial neoplasia caused by high-risk human papillomavirus infection. Accurate early diagnosis is essential because existing screening options such as Pap test, liquid-based cytology, VIA, and HPV DNA testing have limitations and often require colposcopy confirmation. This study presents CerviCAREAI, an AI analysis software that automatically evaluates tele-cervicography images to distinguish low- versus high-grade lesions. In a multicenter retrospective study, CerviCAREAI showed 98% sensitivity and 95.5% specificity for high-risk groups, supporting highly accurate detection of cervical precancerous lesions while further prospective validation is needed.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-artificial-intelligence-based-analysis-software-to-support-screening-system-of-cervical-intraepithelial-neoplasia/337394/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-artificial-intelligence-based-analysis-software-to-support-screening-system-of-cervical-intraepithelial-neoplasia/337394.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does CerviCAREAI address in cervical screening?","Question",{"text":112,"@type":113},"CerviCAREAI targets challenges in colposcopy-based diagnosis by automatically analyzing tele-cervicography images to help distinguish low-grade from high-grade lesions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CerviCAREAI’s diagnostic performance results evaluated?",{"text":117,"@type":113},"Performance was assessed in a multicenter retrospective study using sensitivity and specificity metrics for defined high-risk groups.",{"name":119,"@type":110,"acceptedAnswer":120},"What were CerviCAREAI’s reported sensitivity and specificity values?",{"text":121,"@type":113},"CerviCAREAI achieved 98% sensitivity for high-risk groups and 95.5% specificity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337394,1790523444,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDevelopment and validation of artificial intelligence‑based analysis software to support screening system of cervical intraepithelial neoplasia  \nYung‑TaekOuh1, Tae Jin Kim2, Woong Ju3, Sang Wun Kim4, SeobJeon5, Soo‑Nyung Kim6, Kwang Gi Kim7 & Jae‑Kwan Lee8*  \nCervical cancer, the fourth most common cancer among women worldwide, often proves fatal and stems from precursor lesions caused by high‑risk human papillomavirus (HR‑HPV) infection. Accurate and early diagnosis is crucial for effective treatment. Current screening methods, such as the Pap test, liquid‑based cytology (LBC), visual inspection with acetic acid (VIA), and HPV DNA testing, have limitations, requiring confirmation through colposcopy. This study introduces CerviCAREAI, an artificial intelligence (AI) analysis software, to address colposcopy challenges. It automatically analyzesTele‑cervicography images, distinguishing between low‑grade and high‑grade lesions. In amulticenter retrospective study, CerviCAREAI achieved a remarkable sensitivity of 98% for high‑risk groups (P2, P3, HSIL or higher, CIN2 or higher) and a specificity of 95.5%. These findings underscore CerviCAREAI’s potential as a valuable diagnostic tool for highly accurate identification of cervical precancerous lesions. While further prospective research is needed to validate its clinical utility, this AI system holds promise for improving cervical cancer screening and lessening the burden of this deadly disease.  \nCervical cancer remains the fourth most common cancer among women worldwide1–3. Cervical cancer is a wellknown cause of death for women worldwide and develops from precursor lesions known as cervical intraepithelial neoplasia (CIN)4,5. It also develops through persistent infection with high-risk human papillomavirus (HRHPV)3. The terms low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL) are presently used to describe the histological classification of cervical dysplasia6,7. This disease grading is used as a basis for patient management and subsequent treatment, and LSIL and HSIL, respectively, refer to CIN1 and CIN2 or CIN3 subgroups.  \nCurrently, the World Health Organization (WHO) recommends three distinct screening tests: the traditional Pap test with liquid-based cytology (LBC), and visual inspection with acetic acid (VIA)8. HPV DNA testing for high-risk HPV types is also recommended. Colposcopic guided biopsy is currently often utilized to diagnose cervical cancer. According to the American Society for Colposcopy and Cervical Pathology (ASCCP) recommendations, those with positive results from cytology or an HPV test were referred for Colposcopy8. Patients  \n1Department of Obstetrics and Gynecology, Korea University Ansan Hospital, 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, Republic of Korea. 2Department of Obstetrics and Gynecology, Konkuk University School of Medicine, 120-1, Neungdong-ro, Gwangjin-gu, Seoul, Republic of Korea. 3Department of Obstetrics and Gynecology, Ewha Womans University Seoul Hospital, 25, Magokdong-ro 2-gil, Gangseo-gu, Seoul, Republic of Korea. 4Department of Obstetrics and Gynecology, Institute of Women’s Life Medical Science, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea. 5Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University Cheonan Hospital, 31, Suncheonhyang 6-gil, Dongnam-gu, Cheonan-si, Chungcheongnam-do, Republic of Korea. 6R&D Center, NTL Medical Institute, Yongin, Republic of Korea. 7Department of Biomedical Engineering, Gachon University College of Medicine, Gil Medical Center, 24, Namdong-daero 774beon-gil, Namdong-gu, Incheon, Republic of Korea. 8Department of Obstetricsand Gynecology, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, Republic of Korea. *email: [jklee38@korea.ac.kr](jklee38@korea.ac.kr)  \n[www. ","cbCaiiwh6yqFgFmf","https://ap.wps.com/l/cbCaiiwh6yqFgFmf","pdf",1900596,"English","# Background\n## Limitations of current cervical cancer screening\n## Role of colposcopy and cervicography/tele-cervicography\n# Study aim\n## Development of CerviCAREAI\n# Methods\n## Multicenter retrospective evaluation\n# Results\n## Sensitivity and specificity for high-risk groups\n# Discussion\n## Clinical potential and need for prospective validation","[{\"question\":\"What problem does CerviCAREAI address in cervical screening?\",\"answer\":\"CerviCAREAI targets challenges in colposcopy-based diagnosis by automatically analyzing tele-cervicography images to help distinguish low-grade from high-grade lesions.\"},{\"question\":\"How were CerviCAREAI’s diagnostic performance results evaluated?\",\"answer\":\"Performance was assessed in a multicenter retrospective study using sensitivity and specificity metrics for defined high-risk groups.\"},{\"question\":\"What were CerviCAREAI’s reported sensitivity and specificity values?\",\"answer\":\"CerviCAREAI achieved 98% sensitivity for high-risk groups and 95.5% specificity.\"}]","Development and validation of artificial intelligence-based analysis software to support screening system of cervical intraepithelial neoplasia | PDF",1790018968,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bf2c93e73003c645ce77a8d3f05cced.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d9c636691631a841fdd3b9c08258937.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7adf0e0ef6e27550b2f259d644503ce.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff7f69a08b7ef1315ec8bc88a64dc75d.webp",980,1287]